Opinion

Podcast

Untapped Potentials: Exploring Overlooked Therapies for Type 2 Diabetes

In this episode of MEDcast, the expert panelists examine some underutilized therapies in type 2 diabetes (T2D) and explore their potential as effective treatment choices for many patients.

To watch the video series component of this episode, click here.

0:50 Need for using older diabetes medications

3:30 Quick-release bromocriptine: benefits in T2D and cardiovascular risk

6:15 Efficacy of quick-release bromocriptine

8:10 Quick-release bromocriptine as monotherapy and as an add-on

9:00 Mechanism of quick-release bromocriptine

11:41 Titrating quick-release bromocriptine

15:50 Benefits of pioglitazone

22:30 Positioning older T2D therapies in the current treatment regimen

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.